Skip to main content

Advertisement

SpringerLink
Log in

Oral administration of eicosapentaenoic acid suppresses liver fibrosis in postoperative patients with biliary atresia

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Purpose

Biliary atresia (BA) is characterized by progressive inflammation of the biliary system. This inflammation persists and causes liver fibrosis, although jaundice disappears after Kasai portoenterostomy (KP). We aimed to confirm whether the oral administration of eicosapentaenoic acid (EPA) suppresses liver fibrosis in postoperative patients with BA.

Methods

We reviewed patients who underwent laparoscopic KP (lapKP) between January 2014 and September 2017. From December 2016, 30 mg/kg/day of EPA was orally administered to patients who opted to take medicine (EPA group). Patients who did not receive EPA were assigned to the non-EPA group. Mac-2 binding protein sugar chain modified isomer (M2BPGi) and hyaluronic acid (HA) levels were compared between the two groups in patients showing disappearance of jaundice at 6 months after the first lapKP.

Results

Seventeen patients in the non-EPA group and 11 in the EPA group were enrolled. At 6 months after the first lapKP, 10 patients in the non-EPA group and six in the EPA group were without jaundice. M2BPGi and HA levels were significantly lower in the EPA group.

Conclusions

Liver fibrosis was suppressed in patients without jaundice 6 months after lapKP, who were administered EPA. We believe that periductular inflammation was alleviated by EPA supplementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Harada K (2017) Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity. Pediatr Surg Int 33(12):1243–1248. https://doi.org/10.1007/s00383-017-4154-8

    Article  PubMed  Google Scholar 

  2. Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Uemoto S (2017) Liver transplantation for biliary atresia: a systematic review. Pediatr Surg Int 33(12):1289–1295. https://doi.org/10.1007/s00383-017-4173-5

    Article  PubMed  Google Scholar 

  3. Sanada Y, Mizuta K, Urahashi T, Ihara Y, Wakiya T, Okada N, Yamada N, Egami S, Ushijima K, Otomo S, Sakamoto K, Yasuda Y, Kawarasaki H (2011) Indication of liver transplantation for jaundice-free biliary atresia with portal hypertension. Ann Transpl 16(4):7–11

    Article  Google Scholar 

  4. Das UN (2006) Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 1(4):420–439. https://doi.org/10.1002/biot.200600012

    Article  PubMed  CAS  Google Scholar 

  5. Nio M, Sasaki H, Tanaka H, Okamura A (2013) Redo surgery for biliary atresia. Pediatr Surg Int 29(10):989–993. https://doi.org/10.1007/s00383-013-3396-3

    Article  PubMed  Google Scholar 

  6. Bates MD, Bucuvalas JC, Alonso MH, Ryckman FC (1998) Biliary atresia: pathogenesis and treatment. Sem Liver Dis 18(3):281–293. https://doi.org/10.1055/s-2007-1007164

    Article  CAS  Google Scholar 

  7. Nio M (2017) Japanese Biliary Atresia Registry. Pediatr Surg Int 33(12):1319–1325. https://doi.org/10.1007/s00383-017-4160-x

    Article  PubMed  Google Scholar 

  8. Sumida W, Kaneko K, Ono Y, Tainaka T, Ando H (2009) Different polyunsaturated fatty acid profiles in patients with biliary atresia after successful Kasai operation and liver transplantation. Pediatr Surg Int 25(3):255–259. https://doi.org/10.1007/s00383-009-2324-z

    Article  PubMed  Google Scholar 

  9. Lee S, Kim S, Le HD, Meisel J, Strijbosch RA, Nose V, Puder M (2008) Reduction of hepatocellular injury after common bile duct ligation using omega-3 fatty acids. J Pediatr Surg 43(11):2010–2015. https://doi.org/10.1016/j.jpedsurg.2008.05.030

    Article  PubMed  Google Scholar 

  10. Dong R, Zheng S (2015) Interleukin-8: a critical chemokine in biliary atresia. J Gastroenterol Hepatol 30(6):970–976. https://doi.org/10.1111/jgh.12900

    Article  PubMed  CAS  Google Scholar 

  11. Storey A, McArdle F, Friedmann PS, Jackson MJ, Rhodes LE (2005) Eicosapentaenoic acid and docosahexaenoic acid reduce UVB- and TNF-alpha-induced IL-8 secretion in keratinocytes and UVB-induced IL-8 in fibroblasts. J Invest Dermatol 124(1):248–255. https://doi.org/10.1111/j.0022-202X.2004.23543.x

    Article  PubMed  CAS  Google Scholar 

  12. Tang N, Zhang Y, Liu Z, Fu T, Liang Q, Ai X (2016) Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis. Biomed Rep 5(1):107–112. https://doi.org/10.3892/br.2016.681

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Shirabe K, Bekki Y, Gantumur D, Araki K, Ishii N, Kuno A, Narimatsu H, Mizokami M (2018) Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. https://doi.org/10.1007/s00535-017-1425-z

    Article  PubMed  Google Scholar 

  14. Yamada N, Sanada Y, Tashiro M, Hirata Y, Okada N, Ihara Y, Urahashi T, Mizuta K (2017) Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol 52(2):245–252. https://doi.org/10.1007/s00535-016-1235-8

    Article  PubMed  CAS  Google Scholar 

  15. Hasegawa T, Sasaki T, Kimura T, Hoki M, Okada A, Mushiake S, Yagi M, Imura K (2000) Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia. J Pediatr Surg 35(11):1643–1646

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan

    Wataru Sumida, Hiroo Uchida, Takahisa Tainaka, Chiyoe Shirota, Akinari Hinoki, Takazumi Kato, Kazuki Yokota, Kazuo Oshima, Ryo Shirotuki, Kosuke Chiba & Yujiro Tanaka

Authors
  1. Wataru Sumida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroo Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takahisa Tainaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chiyoe Shirota
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akinari Hinoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takazumi Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuki Yokota
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kazuo Oshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ryo Shirotuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kosuke Chiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yujiro Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wataru Sumida.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sumida, W., Uchida, H., Tainaka, T. et al. Oral administration of eicosapentaenoic acid suppresses liver fibrosis in postoperative patients with biliary atresia. Pediatr Surg Int 34, 1059–1063 (2018). https://doi.org/10.1007/s00383-018-4313-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-018-4313-6

Keywords

Search

Navigation